Declining Currencies Abroad Mean More Competition To India Drug Makers
This article was originally published in PharmAsia News
Executive Summary
Increased U.S. competition made possible by the declining value of the dollar is expected to eat into the profit of Indian drug makers this year. Analysts also attribute the profit decline to pricing pressures in the generics sector of the industry. Depreciating currencies also will make competition stronger from other countries as well as the United States, analysts say. Some of the decline is expected to be offset by cheaper raw materials imported to India. (Click here for more
You may also be interested in...
Ultrahuman Expands Wearable Medtech Production Into US After $35M Funding Round
Firm operating in London, India and United Arab Emirates says its “Ultra Factory” will open in Indiana within the next six months with end-to-end production based on its operational facility in India.
Cochlear’s Osia System Receives Expanded FDA Clearance For Use In Younger Children
Kids ages 5 and up now can benefit from Cochlear’s Osia implant and sound processor, indicated for hearing loss, mixed hearing loss and single-sided sensorineural deafness.
MAISI: Navigating The 'Valley Of Death' In Medtech Research Translation
Translating research from proof of concept to clinical investigations is a difficult hurdle to overcome. To succeed, researchers need to design their technology for industrial standard manufacturing early on, Anne Vanhoestenberghe, director for the Manufacture of Active Implants and Surgical Instruments (MAISI), told Medtech Insight.